Report: Providers optimistic about clinical decision support tools
Healthcare providers are optimistic about clinical decision support (CDS) tools, according to a new report from healthcare market researcher KLAS.
The report, "Clinical Decision Support 2011: Understanding the Impact," measured levels of impact by asking 344 providers to rate their influence on clinical decisions and standardizing care.
Measured CDS areas included care plans, diagnostic tools, disease reference tools, drug databases, drug reference tools, order sets and surveillance tools. The study examined vendors such as Cerner, EBSCO, Elsevier, First DataBank, Isabel, Logical Images, Thomson Reuters, Wolters Kluwer and Zynx.
Respondents said that poor integration with clinical workflow was the biggest obstacle to CDS success. Additionally, many reported issues with alert fatigue--describing it as an "overly sensitive mess."
Though every CDS segment had key struggles, the Orem, UItah-based researcher noted that providers are optimistic about the future as CDS tools increase in workflow integration, usability and adoption.
The report, "Clinical Decision Support 2011: Understanding the Impact," measured levels of impact by asking 344 providers to rate their influence on clinical decisions and standardizing care.
Measured CDS areas included care plans, diagnostic tools, disease reference tools, drug databases, drug reference tools, order sets and surveillance tools. The study examined vendors such as Cerner, EBSCO, Elsevier, First DataBank, Isabel, Logical Images, Thomson Reuters, Wolters Kluwer and Zynx.
Respondents said that poor integration with clinical workflow was the biggest obstacle to CDS success. Additionally, many reported issues with alert fatigue--describing it as an "overly sensitive mess."
Though every CDS segment had key struggles, the Orem, UItah-based researcher noted that providers are optimistic about the future as CDS tools increase in workflow integration, usability and adoption.